Conduit Pharmaceuticals (NASDAQ:CDT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Conduit Pharmaceuticals (CDT) operate in?

Conduit Pharmaceuticals is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Conduit Pharmaceuticals Stock (NASDAQ: CDT) stock price, news, charts, stock research, profile.

Open	$0.06
Close	$0.07
Volume / Avg.	19.96M / 25.01M
Day Range	$0.06 - $0.08
52 Wk Range	0.06 - 6.73
Market Cap	$8.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	1.86%
Days to Cover	1

Recent News

What's Going On With Conduit Pharmaceuticals Shares Today?

Conduit Pharmaceuticals Inc. (NASDAQ: CDT) shares are trading higher Thursday after the company announced that the Japan Patent Office granted a composition of matter patent for its lead asset, AZD1656. Here's what you need to know.

Vaishali Prayag

Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

S&P 500 Moves Higher; BlackRock Reports Upbeat Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.06
Close	$0.07
Volume / Avg.	19.96M / 25.01M
Day Range	$0.06 - $0.08
52 Wk Range	0.06 - 6.73
Market Cap	$8.50M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	1.86%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Conduit Pharmaceuticals (CDT) stock?

You can purchase shares of Conduit Pharmaceuticals (NASDAQ:CDT) through any online brokerage.

View our list of the best stock brokerages

Who are Conduit Pharmaceuticals (CDT) competitors?

Other companies in Conduit Pharmaceuticals’s space includes: Harvard Bioscience (NASDAQ:HBIO), Quantum-Si (NASDAQ:QSI), Inotiv (NASDAQ:NOTV), Applied DNA Sciences (NASDAQ:APDN) and Lifecore Biomedical (NASDAQ:LFCR).

What is the forecast, or price target, for Conduit Pharmaceuticals (CDT) stock?

There is no analysis for Conduit Pharmaceuticals to provide a consensus price target.

What is the current price for Conduit Pharmaceuticals (CDT)?

The stock price for Conduit Pharmaceuticals (NASDAQ: CDT) is $0.0709 last updated December 20, 2024 at 7:49 PM EST.

Does Conduit Pharmaceuticals (CDT) pay a dividend?

There are no upcoming dividends for Conduit Pharmaceuticals.

When is Conduit Pharmaceuticals (NASDAQ:CDT) reporting earnings?

Conduit Pharmaceuticals’s Q4 earnings are confirmed for Friday, February 14, 2025.

Is Conduit Pharmaceuticals (CDT) going to split?

There is no upcoming split for Conduit Pharmaceuticals.

What sector and industry does Conduit Pharmaceuticals (CDT) operate in?

Conduit Pharmaceuticals is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.

Comments

Conduit Pharmaceuticals

Conduit Pharmaceuticals (CDT) Forecast